Biologic efficacy for complications associated with moderate-to-severe psoriasis
Read time: 4 mins
Last updated:13th Feb 2020
Published:13th Feb 2020
This is the final part of a three-part series on treatments for different patient groups within moderate-to-severe psoriasis. In part 2, we discussed treatments that may be suitable for young women who are of childbearing age. Here we delve into the efficacy of TNF-α treatments in patients who present with more than one feature of psoriasis disease (for example, psoriatic arthritis and nail psoriasis) and for those who have failed on prior biologic treatment.